Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXS3ZX
|
||||
| Drug Name |
2-{[(2R)-1-Butyl-2-pyrrolidinyl]methyl}-4-[(4-chlorophenyl)methyl]-1(2H)-phthalazinone
|
||||
| Synonyms |
CHEMBL2146802
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H28ClN3O
|
||||
| Canonical SMILES |
CCCCN1CCC[C@@H]1CN2N=C(Cc3ccc(Cl)cc3)c4ccccc4C2=O
|
||||
| InChI |
InChI=1S/C24H28ClN3O/c1-2-3-14-27-15-6-7-20(27)17-28-24(29)22-9-5-4-8-21(22)23(26-28)16-18-10-12-19(25)13-11-18/h4-5,8-13,20H,2-3,6-7,14-17H2,1H3/t20-/m1/s1
|
||||
| InChIKey |
YZAHEHXQIMZHAJ-HXUWFJFHSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.